Filing Details

Accession Number:
0001232524-17-000073
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-08 17:39:38
Reporting Period:
2017-03-06
Filing Date:
2017-03-08
Accepted Time:
2017-03-08 17:39:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615763 Paul Treacy Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2017-03-06 355 $131.97 18,108 No 4 S Direct
Ordinary Shares Disposition 2017-03-06 529 $131.97 17,579 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.4935 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes toprovide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.5330 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes toprovide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.